COVID-19 vaccine generated serious reactions to 45 people in Mexico: SSa

COVID-19 vaccine generated serious reactions to 45 people in Mexico: SSa

Serious reactions occurred more frequently among women (Photo: Cuartoscuro) Serious reactions occurred more frequently among women (Photo: Cuartoscuro)

Mexico continues to face the coronavirus pandemic, whose intensity increased between the end of 2020 and the beginning of this year. The government has already started the application of the vaccine from Pfizer laboratories to mitigate the disease, but about 5,693 people have had adverse reactions to the antidote.

Ruy López Riadura, director of the National Center for Preventive Programs and Disease Control (Cenaprece) pointed out during the evening conference on COVID-19 that Of the total cases that reacted, only 45 had severe symptoms and only two have had to be hospitalized for the disease.

These phenomena are registered as Events Supposedly Attributable to Vaccination or Immunization (Esavi) and their most serious expressions were registered in 10 men and 35 women.

Until now, Mexico has applied 673,327 doses of the vaccine, which means that the number of people who had severe reactions represents 0.8%. On the other hand, the two people who required hospital care account for less than 1%.

The average age of people who reacted to the vaccine is 37 years, which, according to López Riadura, reflects the sector of the population that is being vaccinated against the disease, that is, active health workers who are attending the pandemic.

The average age of those who presented serious reactions is 37 years (Photo: Cuartoscuro) The average age of those who presented serious reactions is 37 years (Photo: Cuartoscuro)

Until now, the country’s Ministry of Health reported the application of 670,307 Pfizer-BioNtech vaccines, of which 39,009 people have already received the second dose of the drug.

As to the advances of the first dose at the national level, the authorities reported that it has reached 95%. While the second application advanced mainly in Mexico City, Nuevo León and Coahuila.

The official pointed out that during the vaccination processes a drug surveillance process is maintained to recognize any event that those who received the vaccine present.

“There is a very important critical period that is these thirty minutes of observation, especially that has been defined for the Pfizer vaccine, where after the vaccine people have to be in thirty minutes of observation”Explained López Riadura.

The main reason for this measure is that one of the most serious adverse effects is allergic reactions that can occur within the established period. He pointed out that most of the Esavis that have been registered were identified in those first 30 minutes; Nevertheless, there were other events took place after the observation.

Vaccination in Mexico began in December 2020 (Photo: Cuartoscuro) Vaccination in Mexico began in December 2020 (Photo: Cuartoscuro)

“The idea of ​​the pharmacovigilance system is that Anyone presenting an event, any symptoms, any discomfort, has to seek medical assistance that, having the vaccination history, any event is recorded and studied ”, he pointed out.

Once the reactions are registered, there are committees at the federal and state levels that are in charge of reviewing the cases to determine whether or not they are attributable to the antidote against COVID-19.

Until the last day of January, Mexico has1,864,260 positive cases accumulated and 158,536 deaths from COVID-19 at the national level.

In the last 24 hours, the health agency registered 7,030 contagions Y 462 deaths caused by the disease caused by the SARS-CoV-2 virus.

The official also announced that it is estimated that 104,963 (5%) patients had symptoms in the last 14 days. People with this characteristic are considered “active cases”, as they are capable of spreading the disease.

MORE ON THIS TOPIC:

Coronavirus in Mexico: 7,030 infections and 462 deaths were registered in 24 hours

Experts analyze if the COVID-19 variant detected in Jalisco may be a Mexican mutation

Cofepris authorized laboratories at the CDMX airport for COVID-19 tests

Explica News